HealyB. The Yentl syndrome. N Engl J Med, 1991; 325:274–276.
2.
ViraniSS, AlonsoA, BenjaminEJ, et al.Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation, 2020; 141:e139–e596.
3.
CurtinSC. Trends in cancer and heart disease death rates among adults aged 45–64: United States, 1999–2017. Natl Vital Stat Rep, 2019; 68:1–8.
4.
KheraS, KolteD, GuptaT, et al.Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States. J Am Coll Cardiol, 2015; 66:1961–1972.
5.
AggarwalNR, PatelHN, MehtaLS, et al.Sex differences in ischemic heart disease: Advances, obstacles, and next steps. Circ Cardiovasc Qual Outcomes, 2018; 11:e004437.
6.
AgarwalaA, MichosED, SamadZ, BallantyneCM, ViraniSS. The use of sex-specific factors in the assessment of women's cardiovascular risk. Circulation, 2020; 141:592–599.
7.
GudnadottirGS, AndersenK, ThrainsdottirIS, JamesSK, LagerqvistB, GudnasonT. Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes. Am Heart J, 2017; 191:65–74.
8.
SmolinaK, BallL, HumphriesKH, KhanN, MorganSG. Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: Problem for young women. Circ Cardiovasc Qual Outcomes, 2015; 8:586–592.
9.
OkunrintemiV, Valero-ElizondoJ, PatrickB, et al.Gender differences in patient-reported outcomes among adults with atherosclerotic cardiovascular disease. J Am Heart Assoc, 2018; 7:e010498.
10.
LamCSP, ArnottC, BealeAL, et al.Sex differences in heart failure. Eur Heart J, 2019; 40:3859c–3868c.
11.
U.S. Food and Drug Administration. Guidance for industry and Food and Drug Administration staff: Evaluation of sex-specific data in medical device clinical studies. 2014. Available at: https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/evaluation-sex-specific-data-medical-device-clinical-studies-guidance-industry-and-food-and-drug Accessed March22, 2020.
12.
KhanSU, KhanMZ, RiazH, et al.Abstract 13723: Representation of women and older patients in trials of lipid lowering therapy: A systematic review. Circulation, 2019; 140(Suppl. 1):A13723-A.
13.
GhareMI, TirzuiD, AbbottDJ, et al. J Womens Health 2020;29:1246–1255.
